Steris

Q1 FY2027 EarningsQ1 FY27 results delivered a solid beat on both top and bottom lines, with revenue of $1.49B marginally missing consensus by 0.16% while adjusted EPS of $2.59 outperformed expectations of $2.49 by 3.89%. Organic revenue grew 6% YoY, driven primarily by strong demand in the Healthcare (+8%) and Life Sciences (+9%) segments. Despite raising FY27 CapEx guidance to $450M for a new manufacturing center, STERIS reiterated its full-year earnings guidance, signaling confidence in sustained underlying demand across its recurring service and consumable lines.